On January 21st, 2014 reporter Ketaki Gokhale of Bloomberg BusinessWeek published a shocking statement by Bayer Chief Executive Officer Marijn Dekkers as part of their story on drug patents and prices. With respect to the Nexavar drug which we’ve covered extensively on this blog, he was quoted as saying: “We did not develop this medicine for Indians,” “We developed it for western patients who can afford it.” Nexavar of course was the kidney cancer drug for which the IPAB upheld India’s...
↧